Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies.

Tohen M, Case M, Trivedi MH, Thase ME, Burke SJ, Durell TM.

J Clin Psychiatry. 2010 Apr;71(4):451-62. doi: 10.4088/JCP.08m04984gre. Epub 2010 Feb 23.

PMID:
20361905
2.

A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder.

Thase ME, Corya SA, Osuntokun O, Case M, Henley DB, Sanger TM, Watson SB, Dubé S.

J Clin Psychiatry. 2007 Feb;68(2):224-36.

PMID:
17335320
3.

A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.

Corya SA, Perlis RH, Keck PE Jr, Lin DY, Case MG, Williamson DJ, Tohen MF.

J Clin Psychiatry. 2006 May;67(5):798-806.

PMID:
16841630
4.

Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance.

Shelton RC, Williamson DJ, Corya SA, Sanger TM, Van Campen LE, Case M, Briggs SD, Tollefson GD.

J Clin Psychiatry. 2005 Oct;66(10):1289-97.

PMID:
16259543
5.

A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression.

Corya SA, Williamson D, Sanger TM, Briggs SD, Case M, Tollefson G.

Depress Anxiety. 2006;23(6):364-72.

PMID:
16710853
6.

A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.

Brown EB, McElroy SL, Keck PE Jr, Deldar A, Adams DH, Tohen M, Williamson DJ.

J Clin Psychiatry. 2006 Jul;67(7):1025-33.

PMID:
16889444
7.

Association of common variations in the norepinephrine transporter gene with response to olanzapine-fluoxetine combination versus continued-fluoxetine treatment in patients with treatment-resistant depression: a candidate gene analysis.

Houston JP, Lau K, Aris V, Liu W, Fijal BA, Heinloth AN, Perlis RH.

J Clin Psychiatry. 2012 Jun;73(6):878-85. doi: 10.4088/JCP.10m06744. Epub 2012 Mar 6.

PMID:
22480387
8.

Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.

Keck PE Jr, Corya SA, Altshuler LL, Ketter TA, McElroy SL, Case M, Briggs SD, Tohen M.

J Clin Psychiatry. 2005 May;66(5):611-6.

PMID:
15889948
9.

An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.

Trivedi MH, Thase ME, Osuntokun O, Henley DB, Case M, Watson SB, Campbell GM, Corya SA.

J Clin Psychiatry. 2009 Mar;70(3):387-96. Epub 2009 Mar 10.

PMID:
19284928
10.
11.

Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.

Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.

J Clin Psychiatry. 2009 Oct;70(10):1424-31. doi: 10.4088/JCP.08m04772gre.

PMID:
19906346
12.

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.

Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A.

Arch Gen Psychiatry. 2003 Nov;60(11):1079-88. Erratum in: Arch Gen Psychiatry. 2004 Feb;61(2):176.

PMID:
14609883
13.

Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression.

Brown E, Dunner DL, McElroy SL, Keck PE, Adams DH, Degenhardt E, Tohen M, Houston JP.

Int J Neuropsychopharmacol. 2009 Jul;12(6):773-82. doi: 10.1017/S1461145708009735. Epub 2008 Dec 11.

PMID:
19079815
14.

Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination: a 76-week open-label study.

Corya SA, Andersen SW, Detke HC, Kelly LS, Van Campen LE, Sanger TM, Williamson DJ, Dubé S.

J Clin Psychiatry. 2003 Nov;64(11):1349-56. Erratum in: J Clin Psychiatry. 2004 Feb;65(2):279.

PMID:
14658950
17.

Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.

Sanger TM, Grundy SL, Gibson PJ, Namjoshi MA, Greaney MG, Tohen MF.

J Clin Psychiatry. 2001 Apr;62(4):273-81.

PMID:
11379842
18.
19.

Onset of antidepressant effect of olanzapine and olanzapine/fluoxetine combination in bipolar depression.

Dubé S, Tollefson GD, Thase ME, Briggs SD, Van Campen LE, Case M, Tohen M.

Bipolar Disord. 2007 Sep;9(6):618-27.

PMID:
17845277
20.

Supplemental Content

Support Center